FIELD: medicine.
SUBSTANCE: invention is related to medicine, in particular to ophthalmology. Method is characterised by the fact that concentration of IFN-α is determined in blood serum and tear in patients with hypertension, and if its value is accordingly less than 4.3 pkg/ml and more than 212.4 pkg/ml, transition of disease from predisciform stage to disciform stage is predicted.
EFFECT: improved diagnostics of disease.
1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING EARLY MANIFESTATIONS OF AGE-RELATED MACULAR RETINAL DEGENERATION | 2014 |
|
RU2549673C1 |
| METHOD FOR PREDICTING CLINICAL MACULAR DEGENERATION COURSE | 2005 |
|
RU2291433C1 |
| METHOD FOR MACULAR AREA MORPHOMETRIC CHANGES TREATMENT IN CASE OF POLYMORBIDE SOMATIC CONDITIONS | 2016 |
|
RU2622759C1 |
| METHOD FOR TREATING SENILE MACULAR DEGENERATION AT NEOVASCULAR SYNDROME | 2003 |
|
RU2271208C2 |
| METHOD OF TREATING DEGENERATIVE AND DYSTROPHIC RETINAL DISEASES | 2012 |
|
RU2495669C1 |
| METHOD OF LASER TREATMENT OF FUSED DRUSEN IN CASE OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2472476C1 |
| METHOD FOR INTEGRATED TREATMENT OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2506973C2 |
| METHOD FOR ASSESSING FUNCTIONAL STATE OF MACULAR REGION IN RETINAL PATHOLOGY | 2013 |
|
RU2529409C1 |
| METHOD OF TREATING PROGRESSIVE (ACTIVE) SUBMACULAR NEOVASCULAR MEMBRANE (SNM) | 2008 |
|
RU2372087C1 |
| METHOD OF TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2578953C1 |
